Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert J. Adelman currently holds 5,158,162 shares of Elevation Oncology, Inc. (ELEV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Adelman has been a net buyer of ELEV stock. They have purchased $6.0M and sold $4.1M worth of shares.
Robert J. Adelman's most recent insider trade was on Sep 19, 2023, when they sold 247,343 shares at $0.00 per share.
Robert J. Adelman serves as Executive at Elevation Oncology, Inc. (ELEV). They have executed 19 insider transactions totaling $10.1M over their tenure at the company.
Robert J. Adelman holds the position of Executive at Elevation Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert J. Adelman has shown a buying trading pattern, with $6.0M in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert J. Adelman was on Nov 13, 2007, when they purchased $3.0M worth of ARYX shares. This transaction involved 300,000 shares at $10.00 per share.
Robert J. Adelman currently owns 5,158,162 shares of Elevation Oncology, Inc. (ELEV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert J. Adelman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert J. Adelman has 19 Form 4 filings on record as an insider at Elevation Oncology, Inc..
Set alerts for Robert J. Adelman and 40,000+ other insiders.